THYROID EYE DISEASE (TED)
Clinical trials for THYROID EYE DISEASE (TED) explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE (TED) trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE (TED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to shrink bulging eyes in thyroid disease
Disease control Recruiting nowThis study is testing whether an investigational drug called ZL-1109 can safely reduce eye bulging and inflammation in people with active, moderate-to-severe Thyroid Eye Disease. About 99 Chinese participants will be randomly assigned to receive either the drug or a placebo for 2…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New eye disease drug enters human testing phase
Disease control Recruiting nowThis early-stage study aims to test the safety and side effects of a new injectable drug called GenSci098 in people with thyroid eye disease. Researchers will give increasing doses to 76 participants to see how their bodies handle the medication and monitor for any problems. The …
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC